Research Article

Development and Application of an UHPLC-MS/MS Method for Comparative Pharmacokinetic Study of Eight Major Bioactive Components from Yin Chen Hao Tang in Normal and Acute Liver Injured Rats

Table 3

Pharmacokinetic parameters for eight compounds in plasma after oral administration of YCHT.

Pharmacokinetic Parametert1/2 (h)C (μg/L)T (h)AUC (ug/Lh)AUC (ug/Lh)MRT (h)MRT (h)CLz/F (L/h/kg)Fr (%)

ScoparoneControl2.14 ± 0.71939.32 ± 112.190.54 ± 0.102282.77 ± 390.032347.92 ± 428.693.19 ± 0.163.51 ± 0.144.42 ± 0.82227.64
Model1.58 ± 0.131767.17 ± 106.780.33 ± 0.135196.54 ± 513.375197.06 ± 513.333.94 ± 0.263.95 ± 0.261.96 ± 0.23
ScopoletinControl3.62 ± 3.853.53 ± 0.670.19 ± 0.045.86 ± 0.507.41 ± 2.534.40 ± 0.446.90 ± 4.2070.72 ± 16.41123.38
Model2.20 ± 0.823.34 ± 1.190.13 ± 0.057.23 ± 1.847.83 ± 2.004.81 ± 0.435.56 ± 0.6366.11 ± 16.51
GeniposideControl3.55 ± 0.38751.37 ± 47.720.33 ± 0.131940.63 ± 210.721958.65 ± 206.964.57 ± 0.414.80 ± 0.478.84 ± 0.92257.67
Model6.59 ± 2.461863.84 ± 108.530.58 ± 0.205000.36 ± 755.135223.83 ± 746.924.68 ± 0.575.99 ± 0.613.34 ± 0.49
Aloe-emodinControl2.26 ± 1.1515.18 ± 1.680.54 ± 0.1954.61 ± 6.5060.86 ± 6.683.34 ± 0.124.33 ± 0.8444.24 ± 5.84281.30
Model1.98 ± 0.7136.68 ± 3.090.58 ± 0.30153.62 ± 18.13158.71 ± 19.263.68 ± 0.344.07 ± 0.4016.98 ± 2.15
RheinControl4.64 ± 2.14663.62 ± 50.310.33 ± 0.132031.40 ± 385.582074.39 ± 387.774.79 ± 0.365.38 ± 0.494.92 ± 1.11268.45
Model3.62 ± 1.971759.02 ± 140.490.54 ± 0.195453.29 ± 1202.145518.78 ± 1256.464.38 ± 0.414.67 ± 0.651.87 ± 0.43
EmodinControl3.33 ± 1.673.51 ± 0.590.20 ± 0.1710.41 ± 0.8312.06 ± 1.534.94 ± 0.266.65 ± 1.9969.69 ± 8.45112.01
Model3.64 ± 0.793.89 ± 0.890.17 ± 0.0511.66 ± 2.7013.49 ± 2.434.83 ± 0.256.64 ± 0.7863.22 ± 11.47
ChrysophanolControl2.00 ± 0.2334.48 ± 4.990.63 ± 0.2699.34 ± 10.12103.57 ± 10.092.93 ± 0.163.34 ± 0.2121.80 ± 2.08142.23
Model3.12 ± 1.7437.61 ± 6.510.88 ± 0.35141.29 ± 27.92148.47 ± 25.043.43 ± 0.404.20 ± 0.7715.42 ± 2.38
PhyscioneControl2.65 ± 0.998.45 ± 1.611.25 ± 0.2721.05 ± 4.0422.44 ± 5.542.88 ± 0.253.54 ± 0.4926.99 ± 5.66213.68
Model3.06 ± 2.379.99 ± 2.862.58 ± 1.1144.98 ± 13.9248.47 ± 12.744.07 ± 0.405.26 ± 1.3012.63 ± 3.12

p<0.05 compared with control rats.
p<0.01 compared with control rats.